期刊文献+

5-氟尿嘧啶毫微粒的制备工艺 被引量:1

Preparation of 5-fluorouracil PLGA nanoparticles
下载PDF
导出
摘要 以生物可降解材料乳酸乙醇酸共聚物为载体,采用复乳溶剂挥发法结合高压均质法制备5氟-尿嘧啶毫微粒,通过正交试验设计优化5氟-尿嘧啶毫微粒的制备工艺,用透射电镜观察毫微粒的形态,并对所制得毫微粒的平均粒径、载药量、包封率及重现性进行了研究。实验结果表明:优化制备工艺条件下所制得的5-氟尿嘧啶毫微粒为圆整的类球形实体粒子,平均粒径为85.4 nm,载药量为(12.4±0.7)%,包封率为(64.1±5.3)%,制备工艺简单,重现性好。 5-fluorouracil nanoparticles were obtained by alspoly ( L-lactic-co-glycolic acid) (PLGA). In order to W/O/W-liquid drying process using biodegradable materireach submicron size, a high pressure homogenizer to obtain nanoparticles with a high grade of monodispersity was used. The orthogonal test design was used to optimize the conditions of preparation. The shape of the nanoparticles was observed by TEM. The mean diameter and the particle size distribution of nanoparticles, the encapsulation efficiency, the drug loading, the reappearances of pharmaceu- tical technology were investigated. The results indicated that 5-fluorouracil PLGA nanoparticles were sphere like with the mean size of 85.4 nm, the drug loading was ( 12.4 ± 0. 7 ) %, the encapsulation efficiency of nanoparticles was (64. 1±5.3)%.
出处 《南京工业大学学报(自然科学版)》 CAS 2006年第4期52-56,共5页 Journal of Nanjing Tech University(Natural Science Edition)
关键词 5-氟尿嘧啶 乳酸-乙醇酸共聚物 高压均质法 毫微粒 5-fluorouracil PLGA high pressure homogenization nanoparticles
  • 相关文献

参考文献9

  • 1Wendy P,Robert W M,Rebecca W,et al.Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer[J].Int J Radia Oncol Biol Phys,2004,58(5):1487-1495.
  • 2Mukherji G,Murthy R S,Miglani B D.Preparation and evaluation of cellulose nanospheres containing 5-fluorouracil[J].Int J Pharm,1990,65(1):1-7.
  • 3Tingwei B C,Xiaoping T,Janet N,et al.Synthesis and cytotoxicity of 5-fluorouracil/diazeniumdiolate conjugates[J].Bioorg Med Chem,2003,11(23):4971-4975.
  • 4韩晓燕,卫洪波,连建学,王建刚.5-氟尿嘧啶三种给药途径的药代动力学研究[J].河南医科大学学报,1996,31(4):27-31. 被引量:11
  • 5James M A,Matthew S S.Biodegradation and biocompatibility of PLA and PLGA microspheres[J].Advanced Drug Delivery Reviews,1997,28 (1):5-24.
  • 6Maribel T,Maria J A,Madalena M,et al.Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone[J].Eur J Pharm Biopham,2005,59(3):491-500.
  • 7Lamprecht A,Ubrich N,Hombreiro P M,et al.Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification[J].Int J Pharm,1999,184(1):97-105.
  • 8Lamprecht A,Ubrich N,Hombreiro P M,et al.Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique[J].Int J Pharm,2000,196 (2):177-182.
  • 9Muller R H,Mader K,Gohla S.Solid lipid nanoparticles(SLN) for controlled drug delivery-a review of the state of the art[J].Eur J Pharm Biopham,2000,50(1):161-177.

共引文献10

同被引文献22

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部